CART-19 Responses in Human CD19 Transgenic Mice. CART-19 Responses in Human CD19 Transgenic Mice
收藏NIAID Data Ecosystem2026-03-10 收录
官方服务：
资源简介：
This SuperSeries is composed of the SubSeries listed below. Overall design: Refer to individual Series
应用场景：
创建时间：
2017-08-14
相关数据集
Additional file 1 of Improving CAR-T cell function through a targeted cytokine delivery system utilizing car target-modified extracellular vesicles
Supplementary Material 1
DataCite Commons2025-08-26 更新20
North America CAR-T Cell Immunotherapies for Cancer Market
The North America CAR-T Cell Immunotherapies for Cancer report provides a detailed analysis of emerging investment pockets, highlighting current and future market trends. It offers strategic insights
IMR REPORTS20
Type I interferon signaling pathway enhances immune-checkpoint inhibition in KRAS mutant lung tumors [cell lines]
Lung cancer is the leading cause of cancer mortality worldwide. KRAS oncogenes are responsible for at least a quarter of lung adenocarcinomas, the main subtype of lung cancer. After four decades of in
NIAID Data Ecosystem10
4-1BB Co-stimulation Further Enhances Anti-PD-1-Mediated Reinvigoration of Exhausted CD39+ CD8 T Cells from Primary and Metastatic sites of Epithelial Ovarian Cancers. 4-1BB Co-stimulation Further Enhances Anti-PD-1-Mediated Reinvigoration of Exhausted CD39+ CD8 T Cells from Primary and Metastatic sites of Epithelial Ovarian Cancers
4-1BB Co-stimulation Further Enhances Anti-PD-1-Mediated Reinvigoration of Exhausted CD39+ CD8 T Cells from Primary and Metastatic sites of Epithelial Ovarian Cancers Overall design: Compare gene expr
NIAID Data Ecosystem20
Characterization of Natural Killer Cell Sensitivity of Circulating Tumor Cells in Non-small Cell Lung Cancer using Bulk RNA-sequencing. Characterization of Natural Killer Cell Sensitivity of Circulating Tumor Cells in Non-small Cell Lung Cancer using Bulk RNA-sequencing
To investigate whether circulating tumor cells exhibit NK sensitive gene expression profiles, we performed bulk RNA-sequencing on NK sensitive and NK resisitant cell lines, including two in-house deri
NIAID Data Ecosystem10
